Brief: Crescent Biopharma Inc Prices Its Underwritten Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share
15/07/2026 02:48
BRIEF-Crescent Biopharma Inc Prices Its Underwritten Public Offering Of 8,094,793 Ordinary Shares At $14.50 Per Share July 14 (Reuters) - Crescent Biopharma Inc CBIO.O:
CRESCENT BIOPHARMA INC: PRICES ITS UNDERWRITTEN PUBLIC OFFERING OF 8,094,793 ORDINARY SHARES AT $14.50 PER SHARE
CRESCENT BIOPHARMA INC: PRE-FUNDED WARRANTS ARE BEING SOLD AT A PRICE TO THE PUBLIC OF $14.499 PER PRE-FUNDED WARRANT
Source text: ID:nGNX8QKVvp
Further company coverage: CBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering